Meet the Oncology & Hematology Medical Consulting Team

科文斯在欧洲、北美、拉丁美洲和亚洲的国家拥有一支由50多位具有平均23年行业和临床经验的肿瘤内科医师组成的专业团队。科文斯医生的经验从转化/早期开发到产品发布、后期/上市后研究。我们的医疗团队是根据临床、学术和行业经验精心挑选的,涵盖了包括儿科肿瘤在内的大多数肿瘤适应症。

在这个肿瘤医疗队是一个专门的肿瘤医疗顾问团队。该团队提供特定肿瘤适应症的生命周期管理方面的专业知识,包括临床发展规划和策略、目标产品简介的建立、项目可行性、风险评估和执行、注册以及项目和研究级别的医疗监督。他们将在您整个临床过程中与您分享他们的集体专业知识,以帮助您安全有效地为肿瘤患者带来关键治疗。


Meet the Team

Ariel E. Aguiló, MD
高级医疗主管

Ariel Aguiló,医学博士,是阿根廷布宜诺斯艾利斯Covance临床发展服务公司的高级医疗主管。他为客户药物开发项目的临床试验的开发和实施提供专业知识和支持。Aguiló博士负责医学监测和数据审查,为医学战略和临床项目的执行做出贡献,并为科文斯肿瘤领域带来科学的战略领导。他带来了10年的经验,作为医生,医学顾问和医学主任在药物研究和开发的科文斯。在加入科文斯之前,他曾担任布宜诺斯艾利斯Syneos Health的医疗总监,在此之前,他还曾担任布宜诺斯艾利斯IQVIA的医疗顾问。他开始了他的职业生涯,主治医师,胃肠道肿瘤科,医院消化道。阿吉洛博士于2012年加入科文斯。

Ariel E.Aguiló,医学博士,高级医学主任

Stefanella Bortini, PhD, MD
高级医疗主管

Stefanella Bortini, MD, PhD, is Senior Medical Director, Oncology, for Covance Clinical Development Services, based in Milano, Italy. She contributes to the development of Covance policies involving medical, safety and therapeutics, and serves as global lead project physician on assigned projects. Dr. Bortini brings more than 30 years of experience in clinical research to Covance. Before joining the company, she was Senior Director, Medical Affairs, Oncology, for Chiltern International in Milan. She also has held positions with i3 Research, PRA International, Pharmacia & Upjohn, and Eli Lilly. Dr. Bortini is medically licensed by the Italian Board of Medical and Surgical Examiners and holds ECFMG Medical Certification for the U.S. She received her medical degree from the University of Firenze in Italy, and her PhD in Biomedical Engineering from Northwestern University. She joined Covance in July 2019.

Stefanella Bortini,博士,医学博士,高级医学主任

马里兰州贝戈尼亚·德拉斯赫拉斯
高级医疗主管

Dr. Begoña de las Heras Garcia serves as project physician on clients’ drug development projects, oversees three oncology physicians as part of the Covance Medical Consulting Team in Oncology and is building a global network of sites with expertise in early phase oncology. She brings more than 20 years of national and international clinical oncology research experience and joined Covance in 2016.

Before joining Covance, she served as Executive Medical Officer, Early Phase, for Chiltern in the UK. She also has held clinical research positions with Eisai in the UK and a several organizations in Spain including Pivotal CRO, PharmaMar, AstraZeneca and Bristol-Myers Squibb. She has worked as an oncologist consultant in Ntra Sra. Del Prado Hospital, La Paz Hospital, and General Yagüe Hospital. She has provided significant contribution to several INDs, orphan drug applications, and one NDA, and also co-authored eight book chapters, authored/co-authored more than 20 papers in oncology, and delivered more than 40 presentations in Spanish and at international conferences. She is named as an inventor of two patent applications, according to her contribution to clinical trials and is a member of the Spanish Society of Medical Oncology, European Society of Clinical Oncology, American Society of Clinical Oncology and Madrid Medical School.

Begoña de las Heras,医学博士,高级医学主任

何煌,医学博士
高级医疗主管

何煌是科文斯临床发展服务亚太区高级总监,总部位于中国上海。他带来了超过10年的经验,作为医生和研究员在肿瘤,呼吸治疗和药物开发的科文斯。在加入科文斯之前,他曾在上海百时美施贵宝担任肿瘤科/胃肠科病区主任。他还曾担任阿斯利康的呼吸系统高级经理,以及罗氏在上海的肿瘤/胃肠道医疗经理。他在阿斯利康获得了全球冠军和中国首席执行官奖。他在华中科技大学同济医学院附属医院肿瘤科开始了他的职业生涯。他于2019年9月加入科文斯。

何煌,医学博士高级医疗主管

Geoffrey Kannan,博士,医学博士
医疗主管

Geoffrey Kannan,博士,医学博士,是新泽西州普林斯顿市Covance临床发展服务公司的肿瘤学医学主任。Kannan博士担任客户药物开发项目的全球项目主任医师,为临床试验的开发和实施提供医学专业知识和支持。坎南博士带来了超过10年的经验,作为医生和医学主任科文斯,专门从事肿瘤和儿科。在加入科文斯之前,他曾在弗吉尼亚儿科专家担任儿科血液学/肿瘤学和儿科神经肿瘤学。在此之前,他曾担任Dana Farber癌症研究所/波士顿儿童医院/哈佛医学院儿科神经肿瘤科的儿科和儿科神经肿瘤科的讲师。Kannan博士于2018年11月加入Covance,他是30多篇同行评议期刊文章、演讲和摘要的作者或合著者。

Geoffrey Kannan, PhD MD Medical Director

Carlo Lanza, MD, PhD, MSc
执行医务官

Carlo Lanza,医学博士,Covance Clinical Development Services的执行医疗官,总部位于瑞士卢加诺。Lanza博士为Covance客户进行1-4期临床试验的医疗监测和安全性评估。他领导早期阶段和转化研究早期发展项目,包括靶向治疗、小分子、生物制剂和基因治疗。兰扎博士还监督后期发展战略的制定、注册项目的交付和批准。作为一名内科医生和医学主任,他拥有20多年的临床研究和开发经验,专长于儿科和肿瘤学。在加入科文斯之前,他曾担任瑞士日内瓦疟疾药物合资企业的医疗主管。兰扎博士还曾在诺华肿瘤公司、辉瑞全球研发公司和阿斯利康英国公司担任领导职务。卡罗于2012年加入科文斯。

Carlo Lanza,医学博士,理学硕士,执行医疗官

Martine Poelman,医学博士
Executive Medical Director

Martine Poelman是位于比利时布鲁塞尔的Covance临床发展服务公司肿瘤科的执行医疗主管。她为科文斯的客户提供医疗和科学支持,帮助促进血液系统恶性肿瘤的药物开发。作为一名内科医生和医学主任,Martine为Covance带来了30多年的临床研究和开发经验,专长于儿科和肿瘤学。在担任目前的职务之前,Martine曾担任Covance全球肿瘤研究主管15年多,为200多项临床试验提供医学监测。在加入科文斯之前,她曾在布鲁塞尔的礼来担任临床研究医师,血液肿瘤传染病学。在进入研究之前,她曾在荷兰威廉敏娜儿童医院儿科肿瘤科担任骨髓移植和血液肿瘤内科医师。马汀于1996年11月加入科文斯。

Martine-Poelman-WEB

卡迈勒·韦尔·赛尼, MD, MRCP (UK)
高级医疗主管

Dr. Kamal Veer Saini is a board-certified medical oncologist based in Brussels, Belgium. As Senior Medical Director at Covance, he contributes to medical strategy in the oncology area and client consulting and engagement on asset development and all related aspects of medical and scientific execution.

He has more than 15 years of experience in academia and industry, having held numerous posts of increasing seniority across all phases of clinical drug development in various cancer types (solid tumors as well as hematological malignancies) with both regional and global responsibility.

卡迈勒·韦尔·赛尼

Ivana Teodorovic,医学博士
高级医疗主管

Ivana Teodorovic,医学博士, is Senior Medical Director for Covance Clinical Development Services, based in Brussels, Belgium. Dr. Teodorovic serves as project physician and provides scientific support on global and regional oncology studies for Covance clients. She develops, reviews and revises protocols, and coordinates and performs medical monitoring and review of patient data. Dr. Teodorovic brings more than 30 years of experience as a physician and medical director in drug research and development. Before joining Covance, she served more than 10 years as Coordinating Physician for the European Organization for Research and Treatment of Cancer Data Center Company (EORTC) in Brussels, where she authored the SOP-EORTC Tissue Research Policy. Dr. Teodorovic began her career as a certified anatomopathologist at the Institute for Oncology and Radiology in Belgrade, Serbia. She joined Covance in May 2005.

Ivana Teodorovic,医学博士,高级医疗主管